Zolpidem

Intervention

1 paper1 finding

  • 1 lab in 1 country
  • Humans1

Outcomes

1

Alzheimer's disease progression

downin humans1HR 0.69

1 study
  1. Zolpidem decreases alzheimer's disease progression in humans (HR 0.69 [0.56, 0.85]).

    “zolpidem (vs. lorazepam: difference: ‐0.04 [‐0.06, ‐0.01], P=0.002; HR: 0.69 [0.56, 0.85], P<0.001)”

    Humansmild cognitive impairment

    Critical real‐world patient data observation of repurposable drugs from Alzheimer's disease drug development pipeline using Target Trial Emulation

    AAIC 2025 abstract25 Dec 2025

Latest

Nov 2025: 0Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months